These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2882787)
21. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs. Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659 [TBL] [Abstract][Full Text] [Related]
22. The role of parkinsonism and antiparkinsonian therapy in the subsequent development of tardive dyskinesia. Elliott KJ; Lewis S; el-Mallakh RS; Looney SW; Caudill R; Bacani-Oropilla T Ann Clin Psychiatry; 1994 Sep; 6(3):197-203. PubMed ID: 7881501 [TBL] [Abstract][Full Text] [Related]
23. Tardive dyskinesia as a risk factor for negative symptoms. Taylor SJ Br J Psychiatry; 1994 May; 164(5):701-2. PubMed ID: 7921732 [No Abstract] [Full Text] [Related]
24. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions. Dean CE; Kuskowski MA; Caligiuri MP J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811 [TBL] [Abstract][Full Text] [Related]
29. Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism. Arató M; Bagdy G; Perényi A; Béla A Psychiatry Res; 1984 Apr; 11(4):347-51. PubMed ID: 6146151 [TBL] [Abstract][Full Text] [Related]
30. Cognitive performance of medicated schizophrenics with tardive dyskinesia. Collerton D; Fairbairn A; Britton P Psychol Med; 1985 May; 15(2):311-5. PubMed ID: 2862650 [TBL] [Abstract][Full Text] [Related]
31. Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients. Wilms G; Van Ongeval C; Baert AL; Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S Acta Psychiatr Scand; 1992 Apr; 85(4):306-12. PubMed ID: 1375802 [TBL] [Abstract][Full Text] [Related]
32. Lateral ventricular size, psychopathology, and medication response in the psychoses. Luchins DJ; Lewine RR; Meltzer HY Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730 [TBL] [Abstract][Full Text] [Related]
33. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Binder RL; Kazamatsuri H; Nishimura T; McNiel DE Am J Psychiatry; 1987 Nov; 144(11):1494-6. PubMed ID: 2890308 [TBL] [Abstract][Full Text] [Related]
34. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Richardson MA; Haugland G; Craig TJ Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296 [TBL] [Abstract][Full Text] [Related]
35. Association of negative symptoms with tardive dyskinesia in schizophrenic patients. Chiu H; Lau J; Lam L; Shum P Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320 [TBL] [Abstract][Full Text] [Related]
36. [Neuroleptics and nicotine]. Erdmann R Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751 [TBL] [Abstract][Full Text] [Related]
37. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028 [TBL] [Abstract][Full Text] [Related]
38. Patterns of manual dominance in patients with neuroleptic-induced movement disorders. Kern RS; Green MF; Satz P; Wirshing WC Biol Psychiatry; 1991 Sep; 30(5):483-92. PubMed ID: 1681944 [TBL] [Abstract][Full Text] [Related]
39. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME; Chevesich J; Lehrer E; Mosnaim AD Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
40. HLA antigens in drug-induced parkinsonism. Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]